Search
News
Weekly Winners | Super Micro Soars 24%; Lockheed Martin Surges 15%; Dell and RTX Jump 10%
This week, which stocks lagged or dragged? Weekly Winners column keeps up with market trends, helping Tigers sort out the week's hottest sectors, stock winners and important news.Below are top 10 S&P 500 stock gainers for the week ended July 4:Super Micro Sees Strong Margins, Books $60 Billion in Or...Tiger News
Sat, Jul 25
Top Calls on Wall Street: Nvidia, SpaceX, Tesla, AMD, Intel, Dell, Apple, Meta, and More
Here are the biggest calls on Wall Street on Friday:UBS upgrades Amkor Technology to Buy from NeutralUBS says the company’s partnership with Nvidia has plenty of upside. “We view the US$1.5bn NVIDIA strategic partnership supporting Amkor’s on-going ramp of Vera CPU.”Baird reiterates Apple as Outperf...Tiger News
Fri, Jul 24
US Stock Futures Jump While Brent Oil Futures Drop 2%. Pakistan Exploring Restart of US‑Iran Talks
Pakistan is exploring ways to restart US‑Iran talks to end a nearly five‑month‑long war, three Pakistani sources said. Iran interior minister Eskandar Momeni held exploratory talks in Islamabad this week—his second visit in 10 days—and met Pakistani leaders and army chief Asim Munir.The sources warn...Tiger News
Fri, Jul 24
Cloud Computing Shares Fall. Nebius Down Nearly 10%; CoreWeave Down 8%; IREN Down over 6%; Hut 8 Mining Down About 5%; Oracel Down over 2%.
Cloud computing shares fell on Friday. Nebius down nearly 10%; CoreWeave down 8%; IREN down over 6%; Hut 8 Mining down about 5%; Oracel down over 2%.Tiger News
Fri, Jul 24
Dow Rebounds by 120 Points as Oil Surge Eases, Intel Falls After Earnings
Stocks were relatively unchanged on Friday after a tough session in which a sharp spike in oil prices and lackluster earnings from two megacap companies pressured the broader equity market.The Dow Jones Industrial Average climbed 89 points, or about 0.2%. The S&P 500 and Nasdaq Composite traded arou...Tiger News
Fri, Jul 24
Premarket Movers | Amkor Technology Soars 9%; SAP SE Rises 6% as Q2 Cloud Revenue Up 22%; Alibaba Drops 2%; Nokia Declines 3%
Amkor Technology rose 8.86% in pre-market trading, trading at $71.12/share. The surge was driven by the announcement of a multi-year strategic partnership with Nvidia to co-develop next-generation AI semiconductor advanced packaging and test technologies.Under the agreement, Nvidia will invest appro...Tiger News
Fri, Jul 24
Crypto Daily｜Cryptocurrency Exchange BitMEX to Shut Down; Coinbase's Corporate Customers Can Now Accept Payments from AI Agents
Crypto Daily is our column tracking crypto market trends, offering timely insights and valuable updates to keep you informed.Crypto NewsCryptocurrency exchange BitMEX to shut downCryptocurrency exchange BitMEX, whose founders were pardoned by U.S. President Donald Trump last year, said on Thursday i...Tiger News
Fri, Jul 24
SG Morning Brief | Mag 7 Loses $800B as Oil Hits $100 and AI Capex Fears Collide; Intel Surges After Hours
US OvernightThe S&P 500 plunged 1.21% to 7,408.30 — its worst day in a month — the Nasdaq tumbled 2.15% to 25,137.69, briefly breaking below 25,000 for the first time since May, and the Dow fell 506.93 points (-0.97%) to 51,711.65. Two forces collided: Brent crude crossed above $100 per barrel for t...Longport
Fri, Jul 24
CT ENTERPRISE Rebrands as CPBIO: Company completes transition to a biotech-driven business, positioning itself as an integrated life sciences platform
[For Immediate Release] 24 July 2026CPBIO HOLDING COMPANY LIMITED正大生物控股有限公司(Incorporated in Bermuda with members’ limited liability)(Stock code: 03839.HK)CT ENTERPRISE Rebrands as CPBIOCompany completes transition to a biotech-driven business,positioning itself as an integrated life sciences platform(24 July 2026 – Hong Kong) Chia Tai Enterprises International Limited (Stock Code: 03839.HK) is now called CPBIO Holding Company Limited ("CPBIO" or the "Company") with a new corporate logo launch. The new company name marks an importance of a biotech business. Going forward, CPBIO will focus on sustainable farming, biosecurity and food safety, while continuing to expand its global biotechnology platform and working with leading global industry partners to advance animal health and life sciences.Refocusing on Core Strengths to Chart a Long-Term StrategyThe new name reflects the Company’s evolved business structure and strategic direction. Since 2025, animal health and chlortetracycline ("CTC") products have been the Company’s core business, laying the groundwork for its expansion into biotechnology. CPBIO will continue to prioritize high-growth segments such as animal health and biological products, leveraging R&D and technology to strengthen its product pipeline, accelerate the build-out of a globally competitive biotechnology platform and broaden its footprint across the global life sciences value chain.Capturing Industry Opportunities Through Strategic ExpansionAmid global population growth and rising demand for animal protein, issues such as food safety, public health, biosecurity and antimicrobial resistance (AMR) are drawing increasing global attention. Sustainable livestock farming has moved beyond an agricultural concern to become a matter central to global food security and public health. The animal health sector is shifting its focus from disease treatment toward disease prevention and comprehensive health management, with market demand moving beyond traditional veterinary drugs and antibiotics toward integrated solutions spanning disease control, nutritional management, biosecurity, smart farming, and data management.In step with these long-term trends, CPBIO has adopted "Comprehensive Solutions with Proven Results" as its brand philosophy. Taking a full value-chain approach, the Company has built end-to-end capabilities spanning research and development ("R&D"), manufacturing, technical services and global marketing. Anchored by a core portfolio of veterinary products, biological products and feed additives, and supported by biotechnology, precision nutrition and smart farming technologies, CPBIO delivers one-stop animal health solutions to commercial livestock producers around the world. Its offerings span disease prevention, immunization, nutritional optimization, biosecurity and antibiotic alternatives, helping producers enhance farming efficiency, production resilience and food safety.Driving Innovation with a Global VisionCPBIO has built an integrated global footprint spanning multiple countries and regions, covering R&D, application testing, commercial manufacturing, global distribution and technical support. This mature international platform underpins the Company's core products while accelerating the commercialization of new products, technologies and solutions. By integrating its products, sales channels, brand and technical services, CPBIO continues to deepen its market penetration, accelerate the commercialization of its pipeline, and build competitive advantages that are difficult to replicate.Leveraging its global distribution network and cross-industry connections, CPBIO will continue to strengthen its core animal health business while expanding into high-growth areas such as advanced biologicals, precision nutrition, smart livestock farming and pet health. By translating scientific breakthroughs into scalable products and holistic solutions, the Company is building a diversified biotechnology portfolio resilient across industry cycles, strengthening its global competitiveness and long-term earnings potential.Guided by Vision, Driven by MissionPositioned at the forefront of life sciences, CPBIO has grown from a leading supplier of animal health products into a global provider of biotechnology solutions. The Company is guided by its vision of "Becoming a World-leading Biotechnology Company" and its mission: "With innovative biotechnology, advance animal health, protect the earth, and benefit mankind". Anchored by this vision and mission, CPBIO is committed to driving the global livestock industry toward a safer, more efficient and more sustainable future, while continuing to create long-term value for shareholders, customers and partners.– END –About CPBIO Holding Company LimitedCPBIO Holding Company Limited (Stock Code: 03839.HK) (formerly Chia Tai Enterprises International Limited) has been listed on the Main Board of The Stock Exchange of Hong Kong Limited since July 2015. The Company is an integrated life sciences platform that uses biotechnology to drive and support sustainable farming, biosecurity and food safety.Driven by its vision to become a world-leading biotechnology Company, CPBIO harnesses cutting edge innovation to advance animal health, protect the environment, and benefit humankind. Through continuous technological breakthroughs, the Company is at the forefront of delivering safer, more efficient, and more sustainable livestock production solutions worldwide, supporting the future of global food security.CPBIO is a subsidiary of Charoen Pokphand Foods Public Company Limited (CPF.BK), one of the world’s leading agri-food companies listed in Thailand, and is a member of Charoen Pokphand Group (“CP Group”).CP Group operates in 23 countries across a diverse business covering Agro-industry and food, retail and distribution, media and telecommunication, E-commerce and digital, property development and infrastructure, automotive and industrial products, pharmaceuticals and animal health, finance and banking.This press release is issued by DLK Advisory Limited on behalf of CPBIO Holding Company Limited.For enquiries, please contact,DLK Advisory 金通策略Tel: +852 2857 7101Fax:+852 2857 7103File: 3839_Name Change_ENG_20260724_FINAL24/07/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.comEQS
Fri, Jul 24
Trump Says He's Close to Deciding on Large-Scale Strike Against Iran
Axios reports President Trump said he is seriously considering a renewed large-scale military strike on Iran, including attacks more severe than during the “Epic Fury” action. He said the choice would have consequences, has not been finalized and no deadline has been set. Two U.S. officials confirme...Tiger News
Thu, Jul 23
Nasdaq Drops 2.7%. Tesla Tumbles over 14%; Alphabet Down over 7%; Amazon Down 5%; Oracle, Meta Down over 4%; Microsoft Down 3%
US stocks continued to fall. Nasdaq dropped 2.7% while Dow, S&P fell over 1%.Big tech stocks fell. Tesla down 14.5%; Alphabet down over 7%; Amazon down 5%; Oracle, Meta down over 4%; Microsoft down 3%.Tiger News
Thu, Jul 23
Google Future Contract Commitments Rise to $811bn, up Nearly $500bn in Three Months
In a quarterly filing Google said future contract commitments totaled $811bn as of end-June, up nearly $500bn from three months earlier. The amounts are disclosed separately from capital expenditure guidance and reflect procurement under supply agreements and open purchase orders; about $200.7bn is ...Tiger News
Thu, Jul 23
Oil Stocks & ETFs Jump. Battalion Oil Soars Nearly 10%; Sable Offshore, USO up over 6%; UCO, BNO up Around 5%; Equinor, Murphy up over 3%
Oil Stocks & ETFs jumped on Thursday. Battalion Oil soars nearly 10%; Sable Offshore, USO up over 6%; UCO, BNO up around 5%; Equinor, Murphy up over 3%.Tiger News
Thu, Jul 23
Lockheed Martin Stock Soars 11% After Lifting 2026 Forecasts as Pentagon Seeks to Restock Weapons
Defense giant Lockheed Martin lifted its 2026 sales and profit forecasts on Thursday as the Pentagon looks to replenish weapons stockpiles amid a wave of global conflicts.Shares of the company rose 11.57%.President Donald Trump has been urging defense contractors to increase production as the U.S....Tiger News
Thu, Jul 23
Featured Tools
Top News
Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?
US Stocks Mixed as Dow Drops 160 Points; Tech Stocks Lead, Meta Rises 4.5%
Micron Earnings Preview: Five Key Things Memory Investors Need to Watch
【US Pre-Market】Nasdaq Leads Losses in Three Major Stock Index Futures, IONQ Surges Over 11%, RGTI Rises Over 5% as Market Focuses on US-China Summit
Meta Stock Forecast: Muse Monetization Path Is Key as JPMorgan Raises Price Target to $920; Can Stock Hit Record High?
